Source: Tissue Therapies Limited via Medical News Today
Posted: May 30, 2006 3:32 am ET
Summary:
Brisbane-based biotechnology company Tissue Therapies Limited has potentially overcome a major obstacle in developig human embryonic stem cells for medical treatment by discoverinng its VitroGro® technology can be used to replace animal or human serum in the culture of human embryonic stem cells. Research demonstrated that human embryonic stem cells can be successfully grown using Tissue Therapies' VitroGro®, eliminating the need to use human or animal serum to culture cells. Researchers been extremely concerned that the use of animal- or human-derived serum to grow human embryonic stem cells could result in the transmission of infections to humans treated with these cells. Researchers believe the discovery has significant potential to accelerate the practical application of human stem cell therapies to develop cures for a wide range of devastating diseases.
Commentary: Hopefully this will lead to the development of embryonic stem cells that are safe for human transplantation by enabling the growth of cells without contaminants and eliminate the risk of immune system rejection during cell transplantation into human patients.
No comments:
Post a Comment